The QbD Group acquires life sciences consultancy Azierta to reinforce its global vigilance services and expand its presence in Spain

For more than 12 years, Azierta has accompanied organizations in the life sciences industry, especially in the pharmaceutical and medical device sectors, through the entire lifecycle of their products or services. The core services that Azierta provides are safety management and monitoring, regulatory affairs, compliance and GxP, and scientific and medical affairs. These services include supporting the surveillance of life sciences products and providing strategic scientific and regulatory expertise. These aspects drew the attention of QbD who wished to round out its portfolio of complementary services, covering the lifecycle from idea to patient. QbD will be adding Azierta’s vigilance expertise to its services for the medical device and pharmaceutical industries. The combined expertise and capabilities of QbD and Azierta will give clients the benefit of over a decade of experience and broader, more integrated solutions. By joining forces with Azierta’s team in Madrid, the QbD Group, with an office in Barcelona, strengthens their Spanish presence with more than 100 experts. Both partners are focused on providing quality vigilance services and expanding their pool of expert resources not only in Spain and Portugal, but also in Latin America.